Results 161 to 170 of about 5,597,410 (239)

1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitors. [PDF]

Sci Rep
Safaie E, Sayahi MH, Dastyafteh N, Halimi M, Noori M, Mohammadi-Khanaposhtani M, Zonouzi A, Mirzazadeh R, Tajmir-Riahi A, Mojtabavi S, Faramarzi MA, Larijani B, Asadi M, Mahdavi M.   +13 more
europepmc   +1 more source

Ð”ÐµÐ³Ð¸Ð´Ñ€Ð°Ñ‚Ð°Ñ†Ð¸Ñ Ð±Ð¸Ð¾Ñтанола в Ñтилен на окÑидных катализаторах

, 2013
К. Dossumov, Dina Churina, Ðœ. Telbayeva, K. Kalikhanov   +3 more
openalex   +1 more source

Patterns of Heartwood Formation and Its Key Response Signaling Molecules in <i>Dalbergia odorifera</i> T. Chen. [PDF]

Int J Mol Sci
Li J, Zhu Y, Ma G, Li H, Yang Y, Meng H, Wei J.   +6 more
europepmc   +1 more source

Проценка на процедуралната болка кај доноÑени новородени деца во неонатално одделение во Скопје

, 2015
Elizabeta Zisovska
openalex  

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Current applications of indocyanine green fluorescence angiography in trauma patients and its potential impact: a systematic review. [PDF]

BMJ Open
Breuking EA, de Fraiture EJ, Krijgh DD, van Wessem K, de Bruin IG, Hietbrink F, Ruiterkamp J.   +6 more
europepmc   +1 more source

Ðкупунктурен третман за цервикална Ñпондилоза

, 2015
Кристина Козовска, Jihe Zhu, Blagica Arsovska   +2 more
openalex  

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

miR-181a-5p mediates the effects of BMP4 on intestinal cell proliferation and differentiation. [PDF]

Cell Death Dis
Li C, Zhou Y, Yin Z, Jiang Y, Liu J, Weiss HL, Wang Q, Evers BM.   +7 more
europepmc   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source